Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation
Background Pulmonary arterial hypertension (PAH) is a serious disease exhibiting unspecific symptoms, as a result of which diagnosis is often delayed and prognosis is poor. The underlying pathophysiology includes vasoconstriction and remodelling of small pulmonary arteries. As receptor tyrosine kina...
Main Authors: | Joanna Säleby, Habib Bouzina, Salaheldin Ahmed, Jakob Lundgren, Göran Rådegran |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2019-11-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/5/4/00037-2019.full |
Similar Items
-
Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification
by: Habib Bouzina, et al.
Published: (2020-06-01) -
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
by: Mattias Arvidsson, et al.
Published: (2021-04-01) -
Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension
by: Habib Bouzina, et al.
Published: (2018-11-01) -
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
by: Habib Bouzina, et al.
Published: (2019-12-01) -
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
by: Mattias Arvidsson, et al.
Published: (2019-12-01)